Disease burden

May 9, 2026
Implementing Sustainable Liver Health in Europe: A Second EASL–Lancet Commission
In December 2021, the European Association for the Study of the Liver (EASL)–Lancet Commission on liver disease in Europe launched its first report, which highlighted an alarming increase in liver-related mortality in many European countries. The Commission proposed a roadmap for addressing the documented negative trends. However, quoting one of the accompanying Comment articles, “gaining consensus […]

Read More
May 9, 2024
The Economic Argument for Hepatitis B Treatment Simplification and Expansion
Summary One component of decisions regarding hepatitis B virus (HBV) treatment simplification and expansion is the economic perspective. Literature was reviewed for studies which provide estimates for the economic impact of simplifying and expanding treatment eligibility. Eight published studies and four unpublished studies were included and all but one subset of one study found that […]

Read More

English